International Symposium on T cells and T-cell lymphomas in Essen

Members of the Moriggl group travelled to Essen, Germany to join the Symposium on T cells and T-cell lymphomas.

Helena presenting a poster at the Symposium.

Helena Sorger and Tobias Suske presented their PhD research in poster format while Heidi Neubauer gave an interesting talk on her T cell project.

Heidi giving her talk

Thank you to the CONTROL-T consortium for organising this inspiring symposium!

Spin-Off Fellowship for Anna Orlova

Targeting STAT5 Oligomerization in Leukemia

Due to her remarkable research efforts, Dr. Anna Orlova was awarded with the FFG Spin-Off Fellowship which enables her to form her own group within the Moriggl lab. In the course of the fellowship, Anna wants to target cancerous STAT5 oligomerization in Acute Myeloid Leukemia. We are impressed by this great accomplishment!

Read more about Anna’s research here.

Heidi Neubauer is part of the ERA PerMed funded project “JAKSTAT-target”

The project “Novel individualized therapies in JAK/STAT driven T cell malignancies” (Acronym: JAKSTAT-Target) aims to investigate the role of the JAK-STAT pathway in mature T cell lymphomas and to identify potential drugs and drug synergies targeting this pathway.

The consortium of six research groups from Vienna (Heidi Neubauer), Helsinki (Satu Mustjoki, Tero Aittokallio), Cologne (Marco Herling) and Toronto (Patrick Gunning, Benjamin Haibe-Kains) will focus on the entities of T cell prolymphocytic leukemia (T-PLL) and T cell large granular lymphocyte leukemia (T-LGLL), both showing a high incidence of missense mutations in JAK-STAT pathway genes.

The consortium, led by Satu Mustjoki, will uncover new mechanistic insights into these rare diseases and implement machine learning algorithms to predict synergistic effects from genomic, clinical and in vitro drug sensitivity data, ultimately integrating these data into clinical trials.

For more details, please visit the JAK STAT Target Consortium website, the ERA Per Med Newsletter or the affiliated Twitter profile.

March consortium meeting in Helsinki

VetIdeas-Poster-Challenge 2018

Winners VetIdeas-Poster-Challenge by tecnet/Accent: Karin Bayer/Peter Füreder (1. Platz), Anna Orlova (2. Platz), Nina Kramer (3. Platz); im Bild v.l.: Thilo Schmalz (tecnet), Anna Orlova, Peter Füreder, Karin Bayer, Nina Kramer, Florian Schirg (Accent), Christine Ruckenbauer; ©T. Suchanek/Vetmeduni Vienna

Anna Orlova from the Moriggl Lab could impress with her poster at the VetIdeas-Poster-Challenge 2018 and received 1.000EUR for her future research. Congrats Anna!

The Moriggl Lab receives funding within the ERANET Transcan-2 initiative

The project “ERANET-PLL – Implementation of (epi)genetic and metabolic networks in the targeting of T cell prolymphocytic leukemia” was funded within the European ERANET TRANSCAN-2 initiative (Horizon 2020).

The consortium consists of five research groups from Vienna (Richard Moriggl, Philipp Staber), Cologne (Marco Herling), Lyon (Emmanuel Bachy) and Dresden (Ingo Roeder). The consortium, led by Marco Herling, received €1,500,000 in funding, of which €304,720 was allocated to the group in Vienna.

Read more about the ERANET-PLL project.